Presence of Coronary Atherosclerosis† | ||||||
---|---|---|---|---|---|---|
Univariate Analysis | Multiple Logistic Regression | |||||
OR | 95% CI | p | OR | 95% CI | p | |
Age | 1.21 | 1.09–1.34 | <0.01** | 1.25 | 1.10–1.41 | <0.01** |
Male sex | 2.13 | 0.54–8.40 | 0.50 | |||
Duration of disease | 1.04 | 0.99–1.09 | 0.13 | |||
Triglyceride | 1.37 | 0.62–3.01 | 0.43 | |||
Total cholesterol | 1.49 | 0.92–2.42 | 0.10 | |||
HDL | 2.24 | 0.63–7.88 | 0.21 | |||
LDL | 1.54 | 0.83–2.88 | 0.17 | |||
C-reactive protein | 1.19 | 0.91–1.55 | 0.21 | |||
Creatinine | 2.53 | 0.82–3.25 | 0.18 | |||
Hypertension | 5.14 | 1.46–18.1 | 0.01* | |||
Diabetes | 3.86 | 0.23–65.6 | 0.35 | |||
Hyperlipidemia | NA†† | NA†† | — | |||
Smoking | 3.64 | 0.84–15.9 | 0.09 | |||
Rheumatoid factor | 0.82 | 0.24–2.78 | 0.75 | |||
NSAID | 0.32 | 0.04–2.74 | 0.30 | |||
Prednisolone | 2.14 | 0.54–8.39 | 0.28 | |||
DMARD | 0.97 | 0.29–3.27 | 0.97 | |||
CD34+ EPC % | 1.05 | 0.94–1.17 | 0.40 | |||
CD34/KDR+ EPC% | 0.95 | 0.77–1.16 | 0.60 | |||
CD133+ EPC % | 0.23 | 0.05–0.99 | 0.05* | |||
CD133/KDR+ EPC % | 0.18 | 0.29–1.15 | 0.07 | 0.07 | 0.00–0.97 | 0.01** |
↵† Coronary calcium score > 10.
↵†† OR cannot be estimated due to the complete separation of the data, so that we have no case from one of the groups.
↵* p < 0.05.
↵** p < 0.01. EPC: endothelial progenitor cells; DMARD: disease modifying antirheumatic drugs; HDL: high density lipoproteins; LDL: low density lipoproteins; NSAID: nonsteroidal antiinflammatory drugs.